Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02197 CLOVER BIO-B
RT Nominal up2.100 +0.080 (+3.960%)
Latest  |  Final  |  Interim
Non-current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others83,457-7.670%90,390107,439149,720185,790
Land & other Lease Assets2,151-47.331%4,0848,74212,33655,954
Intangible Assets25,036-9.333%27,61333,35439,85934,998
Interests in Asso. & JCEs0--0000
Other Non-current Assets0--00028,035

110,644-9.373%122,087149,535201,915304,777
Current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Inventories4,189-57.515%9,86011,031696,9782,384,340
Trade Receivables1-66.667%340,99324,1060
Cash & Bank Balances87,300-67.380%267,629401,243735,8641,607,409
Other Current Assets39,704-31.946%58,342209,942442,571398,180
Assets Held for Sale0--0000

131,194-60.935%335,834663,2091,899,5194,389,929
Current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Trade Payables103,898-3.787%107,988120,453247,829856,964
S-T Debt & Leases2,084-80.364%10,61386,149326,598317,630
Other Current Liabilities73,395-95.503%1,632,0361,701,0611,702,5761,654,611
Liab asso w/ Assets Held for Sale0--0000

179,377-89.754%1,750,6371,907,6632,277,0032,829,205
Net Current Assets(48,183)-96.594%(1,414,803)(1,244,454)(377,484)1,560,724
Total Assets Less Current Liabilities62,461--(1,292,716)(1,094,919)(175,569)1,865,501
Non-current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
L-T Debt & Leases0--03,4957,85336,738
Other Non-current Liabilities863,66571.157%504,603537,884549,4112,496,900

863,66571.157%504,603541,379557,2642,533,638
Capital and Reserves
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
  Share Capital8390.000%839838838835
  Reserves(802,043)-55.396%(1,798,158)(1,637,136)(733,671)(668,972)
  Others0--0000
Shareholders' Funds(801,204)-55.422%(1,797,319)(1,636,298)(732,833)(668,137)
Non-controlling Interests0--0000
Others0--0000

(801,204)-55.422%(1,797,319)(1,636,298)(732,833)(668,137)
Commitments and Contingent Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Commitments------13,10516,08122,062
Contingent Liabilities------000
Remarks:  Real time quote last updated: 04/09/2026 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 954,976
%Change--
EPS / (LPS)RMB 0.750
NBV Per Share (¥)RMB -0.617
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.